The Future of Early-Stage Medtech Investing: A Global Outlook | LSI Europe '25

This Panel took place at LSI Europe ‘25 Emerging Medtech Summit in London.

Leading venture capital experts from Solas BioVentures, Buenavista Equity Partners, Precision Life Science Partners, MedMountain Ventures, and Mercia Ventures examine global trends and opportunities in early-stage medical technology investments.

This Panel featured:

Dave Adair — Solas BioVentures

Bibi Sattar Marques — Buenavista Equity Partners

Nick Pachuda — Precision Life Science Partners

Branden Rosenhan — MedMountain Ventures

Robert Hornby — Mercia Ventures

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social:

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw